Seroepidemiology of viral hepatitis, HIV and herpes simplex type 2 in the household population aged 21-64 years in Puerto Rico

• Published in: BMC infectious diseases Vol. 10; no. 1; p. 76
• Main Authors: Pérez, Cynthia M, Marrero, Edmir, Meléndez, Marytere, Adrovet, Sandra, Colón, Héctor, Ortiz, Ana P, Soto-Salgado, Marievelisse, Albizu, Carmen, Torres, Esther A, Suárez, Erick
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 23-03-2010; BioMed Central; BMC
• Subjects: Acquired immune deficiency syndrome; Adult; AIDS; Cancer; Demographic aspects; Distribution; Female; Hepatitis; Hepatitis, Viral, Human - epidemiology; Herpes simplex; Herpes Simplex - epidemiology; HIV; HIV infection; HIV Infections - epidemiology; Households; Human immunodeficiency virus; Humans; Logistic Models; Male; Middle Aged; Prevalence; Prevalence studies (Epidemiology); Puerto Rico - epidemiology; Seroepidemiologic Studies; Viral infections; Young Adult; Puerto Rico; United States > US
• ISSN: 1471-2334; 1471-2334
• DOI: 10.1186/1471-2334-10-76

Viral hepatitis and sexually transmitted infections (STIs) are key public health problems that pose an enormous risk for disease transmission in the general population. This study estimated, for the first time, prevalence estimates of serologic markers of HCV, HBV, HAV, HIV and HSV-2 in the adult population of Puerto Rico and assessed variations across sociodemographic and behavioral characteristics.
A seroepidemiologic survey was employed using a stratified cluster probability sample of households in Puerto Rico. Participants completed a face-to-face interview, a self-administered questionnaire using an ACASI system, and provided blood specimens for antibody testing. Prevalence estimates of viral hepatitis, HIV and HSV-2 were estimated using a logistic regression model weighting for the probability of participation in each household block and the inverse of the probability of selection according to geographic strata, households' blocks, and sex distribution.
A total of 1,654 adults participated in the study. Seroprevalence estimates for HCV (2.3%, 95% CI: 1.3%-4.2%), HBV (3.1%, 95% CI: 2.0%-4.7%), and HSV-2 (22.3%, 95% CI: 18.5%-26.7%) in Puerto Rico are roughly in agreement with estimates obtained in the US population; however, HAV (41.3%, 95% CI: 36.9%-45.8%) and HIV (1.1%, 95% CI: 0.5%-2.3%) seroprevalence estimates in Puerto Rico were higher. The proportion of individuals that were unaware of their serostatus was as follows: 80% for HCV, 98.3% for HBV, 96.4% for HAV, 36.4% for HIV, and 97.8% for HSV-2. Post-stratification estimates of seroprevalence varied significantly by demographic and risk related characteristics.
This data underscore the disproportionate impact of some viral infections across selected population subgroups in Puerto Rico. A concerted island-wide effort is needed to strengthen viral hepatitis and STIs prevention and control strategies, support surveillance to monitor chronic infections, and ensure appropriate counseling, testing, and medical management of infected persons. Integration of HCV, HBV, and HSV-2 counseling into HIV existing prevention services and outreach through social networks might represent a valuable approach to reach high-risk individuals.